Baculoviral IAP Repeat-Containing 5 抗体
(Baculoviral IAP Repeat-Containing 5 (BIRC5))
This gene is a member of the inhibitor of apoptosis (IAP) gene family, which encode negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but this gene encodes proteins with only a single BIR domain. The encoded proteins also lack a C-terminus RING finger domain. Gene expression is high during fetal development and in most tumors, yet low in adult tissues. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2011].
Recommended next Filters:
242 results
Carrier-free
BIRC5
适用: 人, 小鼠, 大鼠
WB, ELISA, IHC
宿主: 兔
Polyclonal
unconjugated
Latest Publications for our Baculoviral IAP Repeat-Containing 5 抗体
: "Canstatin represses glioma growth by inhibiting formation of VM-like structures." in: Translational neuroscience, Vol. 12, Issue 1, pp. 309-319, (2021) (PubMed).
: "Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro." in: Cancer investigation, Vol. 38, Issue 1, pp. 23-36, (2020) (PubMed).
: "Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model." in: Cancer letters, Vol. 443, pp. 25-33, (2019) (PubMed).
: "Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription." in: eLife, Vol. 7, (2019) (PubMed).
: "Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma." in: International journal of molecular sciences, Vol. 19, Issue 9, (2019) (PubMed).
: "HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma." in: International journal of cancer, Vol. 142, Issue 9, pp. 1926-1937, (2019) (PubMed).
: "Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562." in: Gene, Vol. 692, pp. 217-222, (2019) (PubMed).
: "CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells." in: International journal of molecular sciences, Vol. 20, Issue 1, (2019) (PubMed).
: "Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity." in: Developmental cell, Vol. 49, Issue 3, pp. 393-408.e7, (2019) (PubMed).
: "The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells." in: European review for medical and pharmacological sciences, Vol. 23, Issue 6, pp. 2681-2690, (2019) (PubMed).
: "Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro." in: Cancer investigation, Vol. 38, Issue 1, pp. 23-36, (2020) (PubMed).
: "Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model." in: Cancer letters, Vol. 443, pp. 25-33, (2019) (PubMed).
: "Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription." in: eLife, Vol. 7, (2019) (PubMed).
: "Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma." in: International journal of molecular sciences, Vol. 19, Issue 9, (2019) (PubMed).
: "HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma." in: International journal of cancer, Vol. 142, Issue 9, pp. 1926-1937, (2019) (PubMed).
: "Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562." in: Gene, Vol. 692, pp. 217-222, (2019) (PubMed).
: "CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells." in: International journal of molecular sciences, Vol. 20, Issue 1, (2019) (PubMed).
: "Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity." in: Developmental cell, Vol. 49, Issue 3, pp. 393-408.e7, (2019) (PubMed).
: "The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells." in: European review for medical and pharmacological sciences, Vol. 23, Issue 6, pp. 2681-2690, (2019) (PubMed).
Aliases for Baculoviral IAP Repeat-Containing 5 抗体
baculoviral IAP repeat containing 5 (BIRC5) 抗体baculoviral IAP repeat-containing 5 (Birc5) 抗体
baculoviral IAP repeat containing 5a (birc5a) 抗体
baculoviral IAP repeat-containing 5, gene 1 L homeolog (birc5.1.L) 抗体
baculoviral IAP repeat containing 5 L homeolog (birc5.2.L) 抗体
baculoviral IAP repeat containing 5b (birc5b) 抗体
baculoviral IAP repeat containing 5 S homeolog (birc5.2.S) 抗体
AAC-11 抗体
AP14 抗体
API4 抗体
Api4 抗体
api4 抗体
BIR1 抗体
bir1-A 抗体
bir5a 抗体
bir5b 抗体
birc5.2 抗体
birc5.2-a 抗体
birc5.2-b 抗体
EPR-1 抗体
epr-1 抗体
SIX 抗体
Su1 抗体
Su2 抗体
survivin 抗体
survivin40 抗体
svv1 抗体
svv2 抗体
TIAP 抗体
XBIR1 抗体
xsurv 抗体
xSurvivin 抗体
XSurvivin1 抗体
xSurvivin2 抗体
Xsvv1 抗体
您还需要查找其他产品吗？
You are here:
